The effects were generally larger in trials that included individuals diagnosed with binge eating disorder or specifically aimed to reduce binge eating
Cluster 3 included GI symptoms such as nausea, pancreatitis, rash, and vomiting
These medications include semaglutide (Ozempic for diabetes, Wegovy for obesity), liraglutide (Victoza for diabetes, Saxenda for obesity), dulaglutide (Trulicity, approved only for diabetes), and tirzepatide (Mounjaro for diabetes, Zepbound for obesity), which is a dual GLP-1/GIP receptor agonist
Tomasi D, Volkow ND (2013) Striatocortical pathway dysfunction in addiction and obesity: differences and similarities
The Medicare GLP-1 Bridge is a temporary nationwide program that lets eligible people with Medicare prescription drug coverage buy certain GLP-1 weight-loss medications for a flat $50 monthly copay, no matter what their income level is
Made with essential fatty acids, it's an easy addition to your wellness routine